- Home
- KROS vs BHB Comparison
KROS vs BHB Comparison
Compare KROS & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BHB
- Stock Information
- Founded
- KROS 2015
- BHB 1887
- Country
- KROS United States
- BHB United States
- Employees
- KROS N/A
- BHB N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BHB Major Banks
- Sector
- KROS Health Care
- BHB Finance
- Exchange
- KROS Nasdaq
- BHB Nasdaq
- Market Cap
- KROS 565.0M
- BHB 535.2M
- IPO Year
- KROS 2020
- BHB 1997
- Fundamental
- Price
- KROS $15.65
- BHB $31.95
- Analyst Decision
- KROS Buy
- BHB Buy
- Analyst Count
- KROS 14
- BHB 2
- Target Price
- KROS $20.56
- BHB $34.00
- AVG Volume (30 Days)
- KROS 445.6K
- BHB 43.5K
- Earning Date
- KROS 11-05-2025
- BHB 10-21-2025
- Dividend Yield
- KROS N/A
- BHB 4.04%
- EPS Growth
- KROS N/A
- BHB N/A
- EPS
- KROS 0.47
- BHB 2.57
- Revenue
- KROS $232,844,000.00
- BHB $147,013,000.00
- Revenue This Year
- KROS $5,579.44
- BHB $18.44
- Revenue Next Year
- KROS N/A
- BHB $14.54
- P/E Ratio
- KROS $33.59
- BHB $12.34
- Revenue Growth
- KROS 85820.30
- BHB 0.49
- 52 Week Low
- KROS $9.12
- BHB $26.43
- 52 Week High
- KROS $72.37
- BHB $38.47
- Technical
- Relative Strength Index (RSI)
- KROS 59.98
- BHB 54.79
- Support Level
- KROS $15.25
- BHB $31.50
- Resistance Level
- KROS $16.00
- BHB $32.80
- Average True Range (ATR)
- KROS 0.61
- BHB 0.71
- MACD
- KROS 0.03
- BHB -0.02
- Stochastic Oscillator
- KROS 78.77
- BHB 70.07
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BHB Bar Harbor Bankshares Inc.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..